Supira Medical

The Supira Medical team is incredibly proud of the excellent progress made this year and is excited for what is to come. Cheers to 2025!

4. And now there are 4 sites enrolling in the Supira U.S. EFS SUPPORT I study!   With incredibly fast startup and efficient screening processes, site principal investigator Dr. Garrett Wong, Dr. Tai Pham, and the entire UC Davis Health team enrolled their initial cases in the Supira U.S. EFS SUPPORT I study.   The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #pVAD #innovation #medtech #makingadifference Nitin Salunke Nicole Haratani Joshua Wallin Gagan Singh

1. 2. 3. One Day. Two Cases. Third Site. Congratulations and thank you to site principal investigator Dr. Annapoorna Kini - along with Dr. Samin K. Sharma and the entire The Mount Sinai Hospital Fuester Heart Hospital staff - for enrolling their initial cases in the Supira U.S. EFS SUPPORT I study. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #pVAD #innovation #medtech #makingadifference Nitin Salunke Nicole Haratani Veronica Neiman Daniel Varghai

Supira Medical is pleased to share another site has enrolled a patient in our U.S. Early Feasibility Study! A sincere thank you to the entire Montefiore Health System team for their support, and especially site principal investigator Dr. Andrea Mignatti for his collaboration on this study.   The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S.   #pVAD #innovation #medtech #makingadifference Nitin Salunke Nicole Haratani Veronica Neiman

ICYMI It’s time to learn from Dr. Gagan Singh on VuMedi as he shares insights on our Supira System, and how it is designed to address the limitations of existing pVADs. Click to view; https://lnkd.in/gXvezkdi The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #pVAD #innovation #medtech #makingadifference

Supira Medical is pleased to announce the launch of its U.S. Early Feasibility Study. Thank you to Dr. David Kandzari and the entire clinical team for their tireless efforts to achieve this important milestone. We look forward to enrolling subsequent patients and expanding to additional sites. Read the full press release here: https://lnkd.in/eZvvbmHY. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S.   #pVAD #innovation #medtech #makingadifference David Kandzari, Gagan Singh, Nitin Salunke, Nicole Haratani, Veronica Neiman

What a way to wrap up #TCT2024! Please join us in thanking Prof. Dr. Alexandre Abizaid, Dr. Carlos Campos, Dr. Fábio Sândoli de Brito Junior, and Dr. Gagan Singh who shared an incredible #livecase broadcast utilizing our Supira System during #HRPCI. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #pVAD #innovation #medtech #makingadifference

Don't miss the Supira System #livecase presentation by Prof. Dr. Alexandre Abizaid, Dr. Carlos Campos, and Dr. Fábio Sândoli de Brito Junior during today's Left Main/Bifurcation session starting at 11am EDT. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #TCT2024 #pVAD #innovation #medtech #makingadifference

Dr. Gagan Singh shared his insights on "Engineering the Future of tMCS", highlighting key design features that differentiate the Supira System during this morning's #TCT2024 Interventions in Mechanical Circulatory Support Devices session. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #innovation #pVAD #medtech #makingadifference

Great presentation today by Dr. Ricardo Costa during the #TCT2024 Interventional Heart Failure #Innovation session! Preliminary results from Supira Medical's Early Feasibility Study support safety and feasibility of the Supira System in #HRPCI. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #pVAD #medtech #makingadifference